Singapore family need S$1.5M growth-stimulating drug for baby with dwarfism - The Independent Singapore News

  • 📰 IndependentSG
  • ⏱ Reading Time:
  • 43 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 63%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

The total treatment would cost S$7M. “Please help Jayden to grow normally like other children, any small amount within your means will give him a chance to grow up pain-free and healthy.” — Amanda Tan, Mother

A family in Singapore is appealing to the public to help raise over a million dollars for a growth-stimulating drug for their nine-month-old son born with dwarfism.

Ms Tan listed out “a host of serious medical issues” Jayden would face growing up, such as short stature, disproportionate growth, nerve compression, spinal deformity, back pain, and recurring knee and joint pains. He could also experience sleep apnea, bladder, or bowel dysfunction or hearing loss.Adult males with achondroplasia have an average height of 131cm, while females grow to about 121cm.

Voxzogo was invented specifically to treat achondroplasia and is the only approved treatment that Jayden could take until he’s 18 years old. In doing so, he can possibly grow 20-30cm more than the average. However, the drug is currently not on the list of medications in Singapore approved for subsidies. It also costs around S$40,000 to S$50,000 per month. The doctor’s letter also estimated the drug to cost S$420,000 per year.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

jesus h krist..$7m 4 a hopefool mirakle kure?

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 9. in HEALTH

Health Health Latest News, Health Health Headlines